Skip Nav Destination
Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
Dual functions of cell-autonomous and non–cell-autonomous ADAM10 activity in granulopoiesis
Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment
Issue Archive
December 22 2011
In this Issue
Table of Contents
Inside Blood
Plenary Paper
TRANSPLANTATION
Allo-HLA–reactive T cells inducing graft-versus-host disease are single peptide specific
Avital L. Amir,Dirk M. van der Steen,Renate S. Hagedoorn,Michel G. D. Kester,Cornelis A. M. van Bergen,Jan W. Drijfhout,Arnoud H. de Ru,J. H. Frederik Falkenburg,Peter A. van Veelen,Mirjam H. M. Heemskerk
Review Article
Clinical Trials and Observations
Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971
CME
Alan S. Gamis,Todd A. Alonzo,Robert B. Gerbing,Joanne M. Hilden,April D. Sorrell,Mukta Sharma,Thomas W. Loew,Robert J. Arceci,Dorothy Barnard,John Doyle,Gita Massey,John Perentesis,Yaddanapudi Ravindranath,Jeffrey Taub,Franklin O. Smith
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV
Clinical Trials & Observations
Alice Fabarius,Armin Leitner,Andreas Hochhaus,Martin C. Müller,Benjamin Hanfstein,Claudia Haferlach,Gudrun Göhring,Brigitte Schlegelberger,Martine Jotterand,Andreas Reiter,Susanne Jung-Munkwitz,Ulrike Proetel,Juliana Schwaab,Wolf-Karsten Hofmann,Jörg Schubert,Hermann Einsele,Anthony D. Ho,Christiane Falge,Lothar Kanz,Andreas Neubauer,Michael Kneba,Frank Stegelmann,Michael Pfreundschuh,Cornelius F. Waller,Karsten Spiekermann,Gabriela M. Baerlocher,Michael Lauseker,Markus Pfirrmann,Joerg Hasford,Susanne Saussele,Rüdiger Hehlmann,for the Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK) and the German CML Study Group
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness
Brief Report
Davide Rossi,Alessio Bruscaggin,Valeria Spina,Silvia Rasi,Hossein Khiabanian,Monica Messina,Marco Fangazio,Tiziana Vaisitti,Sara Monti,Sabina Chiaretti,Anna Guarini,Ilaria Del Giudice,Michaela Cerri,Stefania Cresta,Clara Deambrogi,Ernesto Gargiulo,Valter Gattei,Francesco Forconi,Francesco Bertoni,Silvia Deaglio,Raul Rabadan,Laura Pasqualucci,Robin Foà,Riccardo Dalla-Favera,Gianluca Gaidano
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
Clinical Trials & Observations
Klaus H. Metzeler,Heiko Becker,Kati Maharry,Michael D. Radmacher,Jessica Kohlschmidt,Krzysztof Mrózek,Deedra Nicolet,Susan P. Whitman,Yue-Zhong Wu,Sebastian Schwind,Bayard L. Powell,Thomas H. Carter,Meir Wetzler,Joseph O. Moore,Jonathan E. Kolitz,Maria R. Baer,Andrew J. Carroll,Richard A. Larson,Michael A. Caligiuri,Guido Marcucci,Clara D. Bloomfield
Hematopoiesis and Stem Cells
Dual functions of cell-autonomous and non–cell-autonomous ADAM10 activity in granulopoiesis
Brief Report
Masaki Yoda,Tokuhiro Kimura,Takahide Tohmonda,Shinichi Uchikawa,Takeshi Koba,Jiro Takito,Hideo Morioka,Morio Matsumoto,Daniel C. Link,Kazuhiro Chiba,Yasunori Okada,Yoshiaki Toyama,Keisuke Horiuchi
Immunobiology
Paracrine inhibition of GM-CSF signaling by human cytomegalovirus in monocytes differentiating to dendritic cells
Jérome Carlier,Hélène Martin,Bernard Mariamé,Benjamin Rauwel,Catherine Mengelle,Hugo Weclawiak,Alain Coaquette,Charline Vauchy,Pierre Rohrlich,Nassim Kamar,Lionel Rostaing,Georges Herbein,Christian Davrinche
B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency
Gertjan J. Driessen,Menno C. van Zelm,P. Martin van Hagen,Nico G. Hartwig,Margreet Trip,Adilia Warris,Esther de Vries,Barbara H. Barendregt,Ingrid Pico,Wim Hop,Jacques J. M. van Dongen,Mirjam van der Burg
IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo
Mike Recher,Lucinda J. Berglund,Danielle T. Avery,Morton J. Cowan,Andrew R. Gennery,Joanne Smart,Jane Peake,Melanie Wong,Sung-Yun Pai,Sachin Baxi,Jolan E. Walter,Umaimainthan Palendira,Gillian A. Tangye,Michael Rice,Shannon Brothers,Waleed Al-Herz,Hans Oettgen,Hermann Eibel,Jennifer M. Puck,Federica Cattaneo,John B. Ziegler,Silvia Giliani,Stuart G. Tangye,Luigi D. Notarangelo
Lymphoid Neoplasia
Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment
Brief Report
Olav Erich Yri,Dag Torfoss,Olav Hungnes,Anne Tierens,Kristian Waalen,Tone Nordøy,Susanne Dudman,Anette Kilander,Karin Fahl Wader,Bjørn Østenstad,Roald Ekanger,Peter Meyer,Arne Kolstad
Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease
Sonia D'Souza,Davide del Prete,Shunqian Jin,Quanhong Sun,Alissa J. Huston,Flavia Esteve Kostov,Benedicte Sammut,Chang-Sook Hong,Judith L. Anderson,Kenneth D. Patrene,Shibing Yu,Chinavenmeni S. Velu,Guozhi Xiao,H. Leighton Grimes,G. David Roodman,Deborah L. Galson
FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death
Lapo Alinari,Emilia Mahoney,John Patton,Xiaoli Zhang,Lenguyen Huynh,Christian T. Earl,Rajeswaran Mani,Yicheng Mao,Bo Yu,Carl Quinion,William H. Towns,Ching-Shih Chen,David M. Goldenberg,Kristie A. Blum,John C. Byrd,Natarajan Muthusamy,Mette Prætorius-Ibba,Robert A. Baiocchi
Myeloid Neoplasia
Δ12-prostaglandin J3, an omega-3 fatty acid–derived metabolite, selectively ablates leukemia stem cells in mice
Shailaja Hegde,Naveen Kaushal,Kodihalli C. Ravindra,Christopher Chiaro,Kelsey T. Hafer,Ujjawal H. Gandhi,Jerry T. Thompson,John P. van den Heuvel,Mary J. Kennett,Pamela Hankey,Robert F. Paulson,K. Sandeep Prabhu
Phagocytes, Granulocytes, and Myelopoiesis
Red Cells, Iron, and Erythropoiesis
Control of Plasmodium falciparum erythrocytic cycle: γδ T cells target the red blood cell–invasive merozoites
Giulia Costa,Séverine Loizon,Marianne Guenot,Iulia Mocan,Franck Halary,Geneviève de Saint-Basile,Vincent Pitard,Julie Déchanet-Merville,Jean-François Moreau,Marita Troye-Blomberg,Odile Mercereau-Puijalon,Charlotte Behr
Thrombosis and Hemostasis
Transplantation
Tryptophan catabolism is associated with acute GVHD after human allogeneic stem cell transplantation and indicates activation of indoleamine 2,3-dioxygenase
Karin Landfried,Wentao Zhu,Magdalena C. Waldhier,Ute Schulz,Julia Ammer,Barbara Holler,Daniel Wolff,Matthias Edinger,Katrin Peter,Marina Kreutz,Reinhard Andreesen,Peter J. Oefner,Ernst Holler
Vascular Biology
Correspondence
Errata
Other Departments
-
Cover Image
Cover Image
The image shows immunostaining of an Etv2-null embryo using anti–Flk-1 (red) and anti-PDGFRα (green) antibodies. Despite the loss of Flk-1+ cells committed to blood and endothelial cells in the extraembryonic mesoderm, cardiac progenitors are present as Flk-1+/PDGFRα+ cells in the intraembryonic region. See the article by Kataoka et al on page 6975.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals